Beta-adrenoblocker in heart failure: bisoprolol role
Abstract
Main principles of chronic heart failure (CHF) management are presented, including the role of beta-adrenoblockers (BB), in particular, bisoprolol. BB potential as initial CHF treatment is discussed.
About the Authors
Yu. V. Lukina
State Research Center for Preventive Medicine, State Federal Agency for Health and Social Development, Moscow
Russian Federation
Russian Federation
S. Yu. Martsevich
State Research Center for Preventive Medicine, State Federal Agency for Health and Social Development, Moscow
Russian Federation
Russian Federation
References
1. Национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН (второй пересмотр, 2006), www.cardiosite.ru
2. Агеев Ф.Т., Даниелян М.О., Мареев В.Ю. и др. Больные с хронической сердечной недостаточностью в российской амбулаторной практике: особенности контингента, диагностики и лечения (по материалам исследования ЭПОХА-О-ХСН). Серд недостат 2004; 5(1): 4-7.
3. Swedberg К., Cleland J., Dargie H., et al. Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). Eur HeartJ2005;26: 1115-40.
4. Беленков Ю.Н., Мареев В.Ю., Агеев Ф.Т. Хроническая сердечная недостаточность. Избранные лекции по кардиологии. ГЭОТАР-медицина, Москва 2006; 4-45, 194-247.
5. Packer M. Pathophysiology of heart failure. Lancet 1992; 340: 88-95.
6. CIBIS Investigators and Committees. A randomized trial of b-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 1994; 90: 1763-5.
7. CIBIS II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II(CIBISII): a randomized trial. Lancet 1999; 353: 9-13.
8. Schuchert A., BISEX Investigators. Effects of bisoprolol treatment for chronic heart failure initiated and followed up by primary care physicians. Eur J Heart Failure 2005; 7: 604-11.
9. Willenheimer R., Silke B. Possible clinical implications of the Cardiac Insufficiency Bisoprolol (CIBIS) III trial. The British J Cardiol 2005, 12 (6): 448-54.
10. Heidenreich P.A., Lee T.T., Massie B.M. Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. JACC 1997; 30: 27-34.
11. Komajda M., Lapuerta P., Hermans N., et al. Adherence to guidelines is a predictor of outcome in chronic heart failure: MAHLER survey. Eur Heart J 2005; 26: 1653-9.
Review
For citations:
Lukina Yu.V., Martsevich S.Yu. Beta-adrenoblocker in heart failure: bisoprolol role. Cardiovascular Therapy and Prevention. 2006;5(8):79-82. (In Russ.)
Views:
472
Email this article 
